People · Operator
Named in public records as an officer, director or promoter · active 2009–2009 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Bridge Pharmaceuticals, Inc. | — | Pharmaceuticals | Seed | $2.2M | $83.3M | 2009 |
Thomas Oakley at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Thomas Oakley on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Anthony Sun | 1 | 8 |
| Dennis Purcell | 1 | 5 |
| Carlos Orantes | 1 | 2 |
| Patrik Jeanmonod | 1 | 1 |
| Helen Wong | 1 | 1 |
| Thomas J. De Loia | 1 | 1 |
| Vincent Lagrotteria | 1 | 1 |
| Ronald Marler | 1 | 1 |
| Charles "Jiggs" Davis | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.